Immunogenetics of Toxoplasma gondii informs vaccine design

Trends in Parasitology

Volumn 26, Issue 11, 2010, Pages 550-555

  Henriquez, Fiona L ^a   Woods, Stuart ^b   Cong, Hua ^c,d   McLeod, Rima ^d   Roberts, Craig W ^b  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD8+ T LYMPHOCYTE; ENCEPHALITIS; GENE SEQUENCE; GENETIC RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNOGENETICS; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION; TOXOPLASMA GONDII; TOXOPLASMOSIS; VACCINATION; VACCINE PRODUCTION;

ANIMALS; ANTIGENS, CD8; GENES, MHC CLASS I; H-2 ANTIGENS; HUMANS; MICE; OLIGOPEPTIDES; PROTOZOAN VACCINES; T-LYMPHOCYTES, CYTOTOXIC; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

MURINAE; MUS; TOXOPLASMA GONDII;

EID: 77957926717     PISSN: 14714922     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pt.2010.06.004     Document Type: Review

References (64)

1. Zangerle R., et al. High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii. Med. Microbiol. Immunol. 1991, 180:59-66.
2. Menzies F.M., et al. Immunological control of congenital toxoplasmosis in the murine model. Immunol. Lett. 2008, 115:83-89.
3. Jongert E., et al. Vaccines against Toxoplasma gondii: challenges and opportunities: challenges and opportunities. Mem. Inst. Oswaldo Cruz 2009, 104(2):252-266.
4. Lyons R.E., et al. Toxoplasma gondii tachyzoite-bradyzoite interconversion. Trends Parasitol. 2002, 18:198-201.
5. Roberts C.W., et al. The shikimate pathway and its branches in apicomplexan parasites. J. Infect. Dis. 2002, 185(Suppl. 1):S25-S36.
6. Henriquez S.A., et al. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmunomodulation 2009, 16:122-133.
7. Hermes G., et al. Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection. J. Neuroinflammation 2008, 5:48-85.
8. Brown C.R., McLeod R. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J. Immunol. 1990, 145(10):3438-3441.
9. + T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clin. Exp. Immunol. 1991, 84(2):207-212.
10. Johnson J.J., et al. In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain. J. Immunol. 2002, 169(2):966-973.
11. Blackwell J.M., et al. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H-2 congenic mice. Parasite Immunol. 1993, 15:317-324.
12. Williams D.M., et al. Genetic control of murine resistance to Toxoplasma gondii. Infect. Immun. 1978, 19(2):416-420.
13. Jones T.C., Erb P. H-2 complex-linked resistance in murine toxoplasmosis. J. Infect. Dis. 1985, 151(4):739-740.
14. McLeod R., et al. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J. Immunol. 1989, 143(9):3031-3034.
15. Johnson A.M. Strain-dependent, route of challenge-dependent, murine susceptibility to toxoplasmosis. Z. Parasitenkd. 1984, 70(3):303-309.
16. McLeod R., et al. Immune response associated with early survival after peroral infection with Toxoplasma gondii. J. Immunol. 1989, 142(9):3247-3255.
17. Liesenfeld O., et al. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii. Parasite Immunol. 1999, 21:365-376.
18. Liesenfeld O., et al. Association of CD4+ T cell-dependent, interferon gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 1996, 184:597-607.
19. Suzuki Y., et al. IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 ice following peroral infection with Toxoplasma gondii. J. Immunol. 2000, 164(10):5375-5382.
20. Nickdel M.B., et al. Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol. 2004, 26:75-82.
21. Johnson J., et al. Genetic analysis of influences on survival following Toxoplasma gondii infection. Int. J. Parasitol. 2002, 32:179-185.
22. Suzuki Y., et al. MHC class I gene(s) in the D/L region but not the TNFα gene determines development of toxoplasmic encephalitis in mice. J. Immunol. 1994, 153(10):4649-4654.
23. Brown C.R., et al. Defi{ligature}nitive identifi{ligature}cation of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology 1995, 85(3):419-428.
24. Denkers E.Y., et al. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specifi{ligature}c cytolytic T lymphocytes. J. Immunol. 1993, 150(2):517-526.
25. + T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. J. Immunol. 1991, 147(7):2310-2316.
26. Resende M.G., et al. The role of MHC haplotypes H2d/H2b in mouse resistance/susceptibility to cyst formation is influenced by the lineage of infective Toxoplasma gondii strain. An. Acad. Bras. Cienc. 2008, 80:85-99.
27. Blanchard N., et al. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat. Immunol. 2008, 9:937-944.
28. + T cell epitopes. J. Infect. Dis. 2008, 198:1625-1633.
29. Toebes M., et al. Design and use of conditional MHC class I ligands. Nat. Med. 2006, 12:246-251.
30. Suzuki Y., et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. J. Infect. Dis. 1996, 173(1):265-268.
31. Farquhar H.G. Congenital toxoplasmosis. Report of two cases in twins. Lancet 1950, 2(6638):562-564.
32. Murphy W.F., Flannery J.L. Congenital toxoplasmosis occurring in identical twins. AMA Am. J. Dis. Child. 1952, 84(2):223-226.
33. Couvreur J., et al. Congenital toxoplasmosis in twins: a series of 14 pairs of twins: absence of infection in one twin in two pairs. J. Pediatr. 1976, 89:235-240.
34. Wiswell T.E., et al. Congenital toxoplasmosis in triplets. J. Pediatr. 1984, 105:59-61.
35. Mack D.G., et al. HLA-class II genes modify outcome of Toxoplasma gondii infection. Int. J. Parasitol. 1999, 29:1351-1358.
36. Subauste C.S., et al. Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals. J. Immunol. 1998, 160(7):3403-3411.
37. Albuquerque M.C., et al. The IFN-gamma +874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem. Inst. Oswaldo Cruz 2009, 104:451-455.
38. Tan T.G., et al. Identification of T. gondii epitopes, adjuvants, and host genetic factors that influence protection of mice and humans. Vaccine 2010, 28:3977-3989.
39. Botten J., et al. Identification of protective Lassa Virus epitopes that are restricted by HLA-A2. J. Virol. 2006, 80:8351-8361.
40. Cong H. Multi-epitope DNA vaccine linked to the A2/B subunit of cholera toxin protect mice against Toxoplasma gondii. Vaccine 2008, 26:3913-3921.
41. Dardé L., et al. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J. Parasitol. 1992, 78:786-794.
42. Howe D.K., Sibley L.D. Toxoplasma gondii comprises 3 clonal lineages: correlation of parasitic genotype with human disease. J. Infect. Dis. 1995, 172(6):1561-1566.
43. Su C., et al. Recent expansion of Toxoplasma through enhanced oral transmission. Science 2003, 299:414-416.
44. Grigg M.E., et al. Success and virulence in Toxoplasma as the result of sexual recombination between two distinct ancestries. Science 2001, 294:161-165.
45. Khan A., et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Brazil Emerg. Infect. Dis. 2006, 12(6):942-949.
46. Darde M.L. Toxoplasma gondii, 'new' genotypes and virulence. Parasite 2008, 15(3):366-371.
47. Grigg M.E., et al. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J. Infect. Dis. 2001, 184:633-639.
48. Leng J., et al. Dysregulation of macrophage signal transduction by Toxoplasma gondii: past progress and recent advances. Parasite Immunol. 2009, 31:717-728.
49. Jones L.A., et al. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol. 2006, 28:635-642.
50. Innes E.A. Toxoplasmosis: comparative species susceptibility and host immune response. Comp. Immunol. Microbiol. Infect. Dis. 1997, 20:131-138.
51. Alexander J., et al. Mechanisms of innate resistance to Toxoplasma gondii infection. Philos. Trans. R. Soc. London B Biol. Sci. 1997, 352(1359):1355-1359.
52. Yap G.S., et al. Genetic analysis of host resistance to intracellular pathogens: lessons from studies of Toxoplasma gondii infection. Microbes Infect. 2006, 8:1174-1178.
53. Debierre-Grockiego F., et al. Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J. Immunol. 2007, 179(2):1129-1137.
54. Mun H.S., et al. Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect. Immun. 2005, 73:4634-4642.
55. Aosai F., et al. Toxoplasma gondii-derived heat shock protein 70 stimulates maturation of murine bone marrow-derived dendritic cells via Toll-like receptor 4. Cell Stress Chaperones 2006, 11:13-22.
56. Aliberti J., et al. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 2003, 4:485-490.
57. Combe C.L., et al. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells. Infect. Immun. 2005, 73:4913-4921.
58. Gazzinelli R.T., et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J. Immunol. 1992, 148(6):1792-1796.
59. Nickdel M.B., et al. Counter-protective role for interleukin-5 during acute Toxoplasma gondii infection. Infect. Immun. 2001, 69:1044-1052.
60. Villard O., et al. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Immunol. 1995, 17:233-236.
61. Roberts C.W., et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection. Infect. Immun. 1996, 64(3):897-904.
62. Suzuki Y., et al. IL-4 is protective against development of toxoplasmic encephalitis. J. Immunol. 1996, 157(6):2564-2569.
63. Alexander J., et al. The role of IL-4 in adult acquired and congenital toxoplasmosis. Int. J. Parasitol. 1998, 28:113-120.
64. Gazzinelli R.T., et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 1996, 157(2):798-805.